Received Feb 20, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPA | HEP A (HAVRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | 944915 | — |
Havrix vaccine for adults but although she is 18 years old; This non-serious case was reported by a other health professional via call center representative and described the occurrence of inappropriate age at vaccine administration in a 18-year-old female patient who received HAV (Havrix 1440 adult) (batch number 944915) for prophylaxis. On 17-JAN-2025, the patient received the 1st dose of Havrix 1440 adult. On an unknown date, an unknown time after receiving Havrix 1440 adult, the patient experienced inappropriate age at vaccine administration (Verbatim: Havrix vaccine for adults but although she is 18 years old). The outcome of the inappropriate age at vaccine administration was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: Upon internal review the case was updated on 20-FEB-2025 The Medical Assistant reported that the patient who got the Hepatitis A, Havrix vaccine for adults but although she was 18 years old. Reporter asked that was that is ok. Patient received adult dose instead of pediatric dose, which ed to in Inappropriate age at vaccine administration. Summary of Changes: General tab, Event tab, product tab and narrative was updated.